Edition:
United Kingdom

Aakash B

Mylan shares slide after warning of hit to revenue

05 Nov 2019

Generic drugmaker Mylan NV said on Tuesday reevaluation of its portfolio of medicines will continue next year and cautioned of a hit to revenue, and its shares nearly 6%.

Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge

29 Oct 2019

Pfizer Inc reported a higher-than-expected third-quarter profit on Tuesday on increased sales of cancer drug Ibrance and a strong launch of new heart medicine Vyndaqel, prompting the largest U.S. drugmaker to lift its earnings forecast for the year.

UPDATE 2-Xeris Pharma's low blood sugar treatment wins FDA approval

10 Sep 2019

Sept 10 The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon therapy that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday.

Retrophin scraps nervous system disorder study, shares dive

22 Aug 2019

Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients' ability to conduct daily activities such as eating and walking, sending shares down 30%.

Medtronic hits record high as profit beats, raises annual profit outlook

20 Aug 2019

Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, boosted by higher demand for its surgical instruments and diabetes devices, and the medical device maker raised its forecast for full-year adjusted profit as well.

FDA approves Celgene's bone marrow cancer treatment

16 Aug 2019

The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease.

UPDATE 3-Deciphera shares skyrocket as cancer drug improves progression-free survival

13 Aug 2019

Aug 13 Deciphera Pharmaceuticals Inc's shares more than doubled on Tuesday after the drugmaker said its treatment helped stomach cancer patients live longer without their disease worsening in a late-stage study.

Humana raises 2019 profit forecast on back of second-quarter beat

31 Jul 2019

Health insurer Humana Inc raised its 2019 profit forecast on Wednesday and beat second-quarter earnings estimates, as it reined in costs and recorded higher revenue from its unit that sells Medicare Advantage health plans.

World News